HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
9.78 USD
+0.02 (+0.2%)
9.78 USD
0 (0%)
HLN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. While HLN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
HLN had positive earnings in the past year.
In the past year HLN had a positive cash flow from operations.
HLN had positive earnings in each of the past 5 years.
In the past 5 years HLN always reported a positive cash flow from operatings.
1.2 Ratios
HLN's Return On Assets of 4.20% is amongst the best of the industry. HLN outperforms 85.42% of its industry peers.
HLN has a Return On Equity of 8.92%. This is amongst the best in the industry. HLN outperforms 85.42% of its industry peers.
HLN has a Return On Invested Capital of 6.11%. This is amongst the best in the industry. HLN outperforms 83.85% of its industry peers.
HLN had an Average Return On Invested Capital over the past 3 years of 6.15%. This is significantly below the industry average of 12.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
HLN's Profit Margin of 12.84% is amongst the best of the industry. HLN outperforms 85.42% of its industry peers.
HLN's Profit Margin has improved in the last couple of years.
HLN has a better Operating Margin (21.31%) than 88.54% of its industry peers.
In the last couple of years the Operating Margin of HLN has grown nicely.
The Gross Margin of HLN (60.75%) is better than 69.79% of its industry peers.
HLN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HLN has less shares outstanding
The number of shares outstanding for HLN has been reduced compared to 5 years ago.
HLN has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.30 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
HLN has a better Altman-Z score (2.30) than 61.98% of its industry peers.
HLN has a debt to FCF ratio of 5.11. This is a neutral value as HLN would need 5.11 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 5.11, HLN belongs to the best of the industry, outperforming 81.77% of the companies in the same industry.
HLN has a Debt/Equity ratio of 0.53. This is a neutral value indicating HLN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.53, HLN is not doing good in the industry: 63.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.3 |
ROIC/WACC0.74
WACC8.26%
2.3 Liquidity
HLN has a Current Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, HLN is not doing good in the industry: 82.81% of the companies in the same industry are doing better.
HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLN's Quick ratio of 0.78 is on the low side compared to the rest of the industry. HLN is outperformed by 84.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
HLN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.56% yearly.
Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
Measured over the past years, HLN shows a small growth in Revenue. The Revenue has been growing by 5.78% on average per year.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
Based on estimates for the next years, HLN will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.10% on average per year.
Based on estimates for the next years, HLN will show a small growth in Revenue. The Revenue will grow by 3.76% on average per year.
EPS Next Y5.41%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
EPS Next 5Y10.1%
Revenue Next Year-1.43%
Revenue Next 2Y1.5%
Revenue Next 3Y2.53%
Revenue Next 5Y3.76%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
HLN is valuated rather expensively with a Price/Earnings ratio of 19.96.
Compared to the rest of the industry, the Price/Earnings ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 81.77% of the companies listed in the same industry.
HLN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 17.27, the valuation of HLN can be described as rather expensive.
Based on the Price/Forward Earnings ratio, HLN is valued cheaply inside the industry as 80.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.59. HLN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.96 | ||
| Fwd PE | 17.27 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HLN is valued cheaply inside the industry as 81.77% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, HLN is valued cheaply inside the industry as 84.90% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.62 | ||
| EV/EBITDA | 15.02 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
HLN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.69
PEG (5Y)1.14
EPS Next 2Y7.76%
EPS Next 3Y8.62%
5. Dividend
5.1 Amount
HLN has a Yearly Dividend Yield of 1.84%. Purely for dividend investing, there may be better candidates out there.
HLN's Dividend Yield is rather good when compared to the industry average which is at 6.85. HLN pays more dividend than 92.71% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.34, HLN is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
5.2 History
HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
HLN pays out 39.53% of its income as dividend. This is a sustainable payout ratio.
DP39.53%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
9.78
+0.02 (+0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap43.55B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts80
Price Target11.2 (14.52%)
Short Float %0.2%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.63%
PT rev (3m)-3.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0.17%
EPS NY rev (3m)0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.96 | ||
| Fwd PE | 17.27 | ||
| P/S | 2.93 | ||
| P/FCF | 16.62 | ||
| P/OCF | 14.32 | ||
| P/B | 2.04 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.02 |
EPS(TTM)0.49
EY5.01%
EPS(NY)0.57
Fwd EY5.79%
FCF(TTM)0.59
FCFY6.02%
OCF(TTM)0.68
OCFY6.98%
SpS3.33
BVpS4.8
TBVpS-2.98
PEG (NY)3.69
PEG (5Y)1.14
Graham Number7.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.3 |
F-Score6
WACC8.26%
ROIC/WACC0.74
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.41%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.43%
Revenue Next 2Y1.5%
Revenue Next 3Y2.53%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.25%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
What is the valuation status for HLN stock?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HALEON PLC-ADR (HLN) stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 19.96 and the Price/Book (PB) ratio is 2.04.
How financially healthy is HALEON PLC-ADR?
The financial health rating of HALEON PLC-ADR (HLN) is 4 / 10.